Rising Medication Use Leaves One in Five Older Adults Facing Drug-Interaction Risks

Medication use among older Americans is rising: a USC-led study found that the share taking five or more prescription drugs increased between 2015–16 and 2021–23, while more than one in five remained at risk of a potentially major drug interaction. Although such interactions became somewhat less common, frequently involved medicines included antidepressants, statins and antiplatelet therapies. Other reports warn that some prescriptions—particularly benzodiazepines and sleep medications—may continue long after their original need, despite risks such as impaired balance, cognitive effects and falls; they also describe lingering antibiotic use for uncomplicated diverticulitis and the shift away from routine aspirin to prevent a first cardiovascular event in many older adults. A separate study identified 24 potentially inappropriate prescribing cascades, in which a drug’s side effect is mistaken for a new condition and treated with another medication. The reports point to regular medication reviews and closer coordination among patients, clinicians and pharmacists as ways to reduce unnecessary medicines and preventable harm.
Alongside prescription polypharmacy, supplement polypharmacy also increased among older adults, rising from 12.6% in 2015–16 to 16.7% in 2021–23. The study drew on nationally representative data from nearly 5,000 U.S. adults ages 62 to 85.
A long-term care facility audit found proton pump inhibitor use lasting as long as 1,198 days; 60% of patients were still taking the drugs without a documented explanation for why the prescriptions had not been reconsidered. Long-term use can carry risks including C. diff infection, bone loss, fractures and vitamin B-12 deficiency.
Despite evidence that many patients with uncomplicated diverticulitis recover without antibiotics, a study of about 70,000 visits at 120 U.S. Veterans Affairs facilities found antibiotics were prescribed at approximately 97% of visits.
Benzodiazepine use among Americans 65 and older declined from about 14% in 2015 to 11.5% in 2024, but the decline largely stalled after 2020; use rose among adults over 75 from 2020 to 2024.
Publishers
16
Articles
31
Reach
47